Premanjali Lahiri

Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease

Annalisa Lattanzi, Joab Camarena, Premanjali Lahiri et al. · Science Translational Medicine · 2021 · 150 citations · Full text

Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation

Volker Wiebking, Ciaran M. Lee, Nathalie Mostrel et al. · Haematologica · 2020 · 71 citations · Full text

Cedar Trial in Progress: A First in Human, Phase 1/2 Study of the Correction of a Single Nucleotide Mutation in Autologous HSCs (GPH101) to Convert HbS to HbA for Treating Severe SCD

Julie Kanter, John F. DiPersio, Patrick J. Leavey et al. · Blood · 2021 · 20 citations

One Year Follow-up on the First Patient Treated with Nula-Cel: An Autologous CRISPR/Cas9 Gene Corrected CD34+ Cell Product to Treat Sickle Cell Disease

David C. Shyr, Robert Lowsky, Weston P. Miller et al. · Blood · 2023 · 20 citations

Molecular dynamics of genome editing with CRISPR-Cas9 and rAAV6 virus in human HSPCs to treat sickle cell disease

Liwen Xu, Premanjali Lahiri, Jason Skowronski et al. · Molecular Therapy — Methods & Clinical Development · 2023 · 10 citations · Full text